Brief Summary
Inotuzumab Ozogamicin Expanded Access Program
Approved for marketing
Individual Patients
Drug: Inotuzumab Ozogamicin
Other Name: PF-05208773
Eligibility Criteria
Inclusion Criteria:
-
Exclusion Criteria:
-
Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Pfizer
NCT Number
MeSH Terms
Inotuzumab Ozogamicin